Key Biotech Updates: Duchenne Therapy Lawsuit and FDA Commissioner Makary's Challenges

An overview of critical developments in biotech, including a lawsuit surrounding a Duchenne muscular dystrophy therapy and the White House complications faced by FDA Commissioner Marty Makary, featured in The Readout.